Recruiting studies: Optic Nerve Atrophy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes
Phase N/A · 1 location(s) · University Hospital Southampton NHS Foundation Trust · NCT06645626 Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
NA · 1 location(s) · Peking University First Hospital · NCT07570212 New Non-invasive Modalities for Assessing Retinal Structure and Function
NA · 1 location(s) · Randy Kardon · NCT03475173 Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
Phase N/A · 16 location(s) · Kliniken Beelitz GmbH · NCT04706234 Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION
Phase 1 · 2 location(s) · The Foundation for Orthopaedics and Regenerative Medicine · NCT05147701 A Longitudinal Natural History Study of OPA1-Associated Autosomal-Dominant Optic Atrophy
Phase N/A · 1 location(s) · Ludwig-Maximilians - University of Munich · NCT07729982 Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT03872102 The Swedish BioFINDER 2 Study
NA · 2 location(s) · Skane University Hospital · NCT03174938 Modifiable Variables in Parkinsonism (MVP)
Phase N/A · 1 location(s) · Bastyr University · NCT02194816 North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Phase N/A · 17 location(s) · Columbia University · NCT01694940 Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy
Phase 2/Phase 3 · 1 location(s) · Wuhan Neurophth Biotechnology Limited Company · NCT04912843 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168 Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07509125 Synaptic Loss in Multiple System Atrophy
Phase N/A · 1 location(s) · University of Exeter · NCT05121012 Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy (Myrtle)
Phase 1/Phase 2 · 3 location(s) · PYC Therapeutics · NCT06970106 Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients
Phase 2 · 1 location(s) · GenSight Biologics · NCT07303296 The CurePSP Genetics Program
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT06647641 Monogenic Diabetes Misdiagnosed as Type 1
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT03988764 UPenn Observational Research Repository on Neurodegenerative Disease
Phase N/A · 1 location(s) · University of Pennsylvania · NCT04715399 The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders
NA · 1 location(s) · Queen Mary University of London · NCT06174948 The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism
Phase 2 · 3 location(s) · Haukeland University Hospital · NCT06162013 Metabolomics Analysis According to the Retinal Nerve Fiber Layer in Patients With NOHL Mutations (MétabOCT)
NA · 1 location(s) · Hôpital Necker-Enfants Malades · NCT06682819 Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT02841553 NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106 AI-Enhanced Optimization of Acute Levodopa Challenge Test
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT06949865 Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Phase 3 · 17 location(s) · Laboratoires Thea · NCT06891443 Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
NA · 1 location(s) · Centre Hospitalier Universitaire de Liege · NCT07136844 Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Bioma
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT07392411 Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Phase N/A · 1 location(s) · Casa di Cura San Raffaele Cassino · NCT06596746 Neurologic Stem Cell Treatment Study
NA · 3 location(s) · MD Stem Cells · NCT02795052

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.